Literature DB >> 10958263

Recruitment of depressive patients for a controlled clinical trial in a psychiatric practice.

E M Haberfellner1.   

Abstract

Attempts were made to recruit moderately depressed patients to a randomized double-blind study with a new serotonergic-noradrenergic antidepressant in a psychiatry specialist's practice. Although 216 patients consulting a psychiatrist for depression were screened, none were suitable for recruitment into the study. The most common causes of exclusion were severity of depression (n = 199, 92.1%), concomitant treatment with other psychotropic drugs (n = 124, 57.4%) and pre-treatment with an SSRI or MAO-inhibitor (n = 97, 44.9%). On average, there were 3.4 criteria per patient that resulted in exclusion from the study. The difficulties in recruiting patients demonstrate that psychopharmacological studies with the usual inclusion and exclusion criteria are hardly practicable in an office-based psychiatric practice. Furthermore, the question to what extent results from studies performed under restrictive inclusion and exclusion criteria are applicable to routine care must also be put.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958263     DOI: 10.1055/s-2000-11293

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

1.  Considering Eligibility for Studies of Deep Brain Stimulation for Treatment-Resistant Depression: Insights From a Clinical Trial in Unipolar and Bipolar Depression.

Authors:  Megan M Filkowski; Helen S Mayberg; Paul E Holtzheimer
Journal:  J ECT       Date:  2016-06       Impact factor: 3.635

2.  Psychological Research With Administrative Data Sets: An Underutilized Strategy for Mental Health Services Research.

Authors:  James T Walkup; Philip T Yanos
Journal:  Prof Psychol Res Pr       Date:  2005-10

3.  Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; John W Finney
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

4.  Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010.

Authors:  Keith Humphreys; Natalya C Maisel; Janet C Blodgett; Ingrid L Fuh; John W Finney
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

5.  Development and validation of the BD SX: a brief measure of mood and symptom variability for use with adults with bipolar disorder.

Authors:  Norm O'Rourke; Andrew Sixsmith; David B King; Hamed Yaghoubi-Shahir; Sarah L Canham
Journal:  Int J Bipolar Disord       Date:  2016-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.